✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Zimmer Biomet Holdings Inc

Common Name
Zimmer Biomet Holdings
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
17,000
Ticker
ZBH
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Zimmer Biomet Holdings, Inc. is a leading global medical technology company specializing in the design, manufacture, and marketing of orthopedic reconstructive products. Its portfolio encompasses knee...

Disclosures of Zimmer Biomet Holdings

Explore Zimmer Biomet Holdings's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Zimmer Biomet Holdings's official channels and fully traceable to its official company sources.

The table below lists all of Zimmer Biomet Holdings's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Zimmer Biomet Holdings's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
Sustainability Report
2024
10-K
2024
Financial & Extra-Financial Disclosure
2024
Annual Report
2023
Sustainability Report
2023
Financial & Extra-Financial Disclosure
2023
10-K
2022
Sustainability Report
2022
10-K
2021
Sustainability Report
2021
10-K
2020
Sustainability Report
2020
Annual Report
2020
Annual Report
2020
10-K
2019
Sustainability Report
2019
10-K
2018
Sustainability Report
2018
10-K
2017
Sustainability Report
2017
10-K
2016
Sustainability Report
2016
10-K
2015
Sustainability Report
2015
10-K
2014
10-K
2013
10-K
2012
10-K
2011
10-K
2010
10-K
2009
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?